InvestorsHub Logo
Followers 103
Posts 9634
Boards Moderated 3
Alias Born 11/06/2009

Re: None

Monday, 10/31/2016 2:37:44 PM

Monday, October 31, 2016 2:37:44 PM

Post# of 2543
DEF 14C - http://archive.fast-edgar.com//20161031/AA2ZW22CZC2RP2SD222A2WX29VWNZZ22ZV82/



The companies anticipate that the combined business (incorporating Inovenn and Lifesciencehub) should create potential operating synergies, lower diversified risk, existing sales of products/services, “cross-franchise” opportunities to incorporate patented technologies into new products, access to a wider range of core skills (including marketing, development and formulation), critical mass for the purpose and enhanced access to capital and a greater chance to apply for listing on the London Stock Exchange’s international market for smaller growing companies (AIM) to provide all shareholders liquidity.






Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.